Dr. Andrea Evans graduated from chemical engineering at Queen’s University, medical school at McGill University, has a Master’s degree in Biomedical Physics, and completed her Pediatrics residency and a Master’s degree in Health Services Research at the University of Toronto. Dr. Evans is a general pediatrician at CHEO and Assistant Professor at the University of Ottawa since 2022.
Dr. Evans’ research focus is on improving health outcomes of pediatric populations disproportionally affected by the social determinants of health through policy-focused research that leverages population-based data. She is currently president of the Global Child and Youth Health Section of the Canadian Pediatric Society.
Additional Areas of Research: Population health
Related News
Research Projects
-
Gaps in childhood immunizations and preventive care visits during the COVID‐19 pandemic: a population‐based cohort study of children in Ontario and Manitoba, Canada, 2016-2021
13/07/2023
We aim to quantify differences in immunization and preventive care visits completed before 12 months of age, and between 12 and 24 months of age, for children post COVID-19 pandemic onset, compared to children before pandemic onset in two Canadian provinces, Manitoba (population ~1.4 million) and Ontario (population ~15 million). We capture immunization and well-child visit rates up until September 2021. Due to the disrupted delivery of services, we hypothesized that the proportion of infants and children who received all vaccines or well-child visits would be lower if they were exposed to the pandemic compared to unexposed infants and children. Our secondary objective was to describe and quantify changes in the receipt of individual vaccines and well-child visits.
-
Receipt of adequate prenatal care for privately sponsored versus government-assisted refugees in Ontario, Canada: a population-based cohort study
03/04/2023
Among refugees resettled to Canada, a government-assisted resettlement model was associated with receiving less adequate prenatal care than a private sponsorship model. Government-assisted refugees may benefit from additional support in navigating health care beyond the first year after arrival.